Global Pharmaceutical Marijuana (MMJ) Market was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 9.8% from 2024 to 2030.
The pharmaceutical marijuana (MMJ) market has seen remarkable growth in recent years, driven by increasing acceptance and demand for cannabis-based treatments. Legalization in various regions and the growing body of research supporting the therapeutic benefits of marijuana are key factors contributing to this expansion. According to recent reports, the MMJ market is expected to grow at a compound annual growth rate (CAGR) of over 20% in the next few years. With its potential to treat a wide range of conditions, including chronic pain, anxiety, epilepsy, and more, MMJ has established itself as a strong contender in the global pharmaceutical landscape.
One of the biggest driving forces behind the rise of MMJ is the changing public perception of cannabis. Once seen only as a recreational drug, marijuana is now being widely recognized for its medical properties. This shift is supported by scientific studies demonstrating its effectiveness in managing symptoms of various diseases and conditions, making it an attractive alternative to traditional pharmaceuticals.
Furthermore, governments and regulatory bodies across the globe have started to loosen restrictions on medical marijuana. In the United States, for example, over 30 states have legalized MMJ, with many others likely to follow suit. This regulatory shift has paved the way for new players to enter the market, driving competition and innovation in MMJ products.
The MMJ market is also benefiting from advancements in delivery methods, such as edibles, oils, tinctures, and topicals, which provide consumers with various options to suit their preferences. These innovations have made it easier for patients to incorporate MMJ into their treatment regimens, further driving demand.
As the pharmaceutical marijuana market continues to grow, it’s essential for stakeholders to stay informed about the latest trends and research. The expansion of MMJ into new therapeutic areas and the ongoing evolution of public policy will likely shape the future of this emerging industry.
Get an In-Depth Research Analysis of the Global Pharmaceutical Marijuana (MMJ) Market Size And Forecast [2025-2032]
Who are the largest Global manufacturers in the Pharmaceutical Marijuana (MMJ) industry?
- Canopy Growth Corporation
- GW Pharmaceuticals
- plc
- Aurora Cannabis
- Inc.
- Aphria
- Inc.
- MedReleaf Corporation
- Insys Therapeutics
- Inc.
- CanniMed Therapeutics
- Inc.
- Cara Therapeutics
- Inc.
- United Cannabis Corporation
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Pharmaceutical Marijuana (MMJ) Market Size And Forecast [2025-2032]
What are the factors driving the growth of the Global Pharmaceutical Marijuana (MMJ) Market?
Growing demand for below applications around the world has had a direct impact on the growth of the Global Pharmaceutical Marijuana (MMJ) Market
- Cancer
- Arthritis
- Migraine
- Epilepsy
- Others
What are the types of Pharmaceutical Marijuana (MMJ) available in the Market?
Based on Types the Market is categorized into Below types that held the largest Pharmaceutical Marijuana (MMJ) market share In 2023.
- THC-dominant
- CBD-dominant
- Balanced THC & CBD
Which regions are leading the Global Pharmaceutical Marijuana (MMJ) Market?
- Global (United States, Global and Mexico)
- Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
- Asia-Pacific (China, Global, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
- South America (Brazil, Argentina, Columbia, etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Pharmaceutical Marijuana (MMJ) Market Research Analysis
Detailed TOC of Global Pharmaceutical Marijuana (MMJ) Market Research Report, 2024-2032
1. Introduction of the Global Pharmaceutical Marijuana (MMJ) Market
- Overview of the Market
- Scope of Report
- Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
- Data Mining
- Validation
- Primary Interviews
- List of Data Sources
4. Global Pharmaceutical Marijuana (MMJ) Market Outlook
- Overview
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porters Five Force Model
- Value Chain Analysis
5. Global Pharmaceutical Marijuana (MMJ) Market, By Type
6. Global Pharmaceutical Marijuana (MMJ) Market, By Application
7. Global Pharmaceutical Marijuana (MMJ) Market, By Geography
- Global
- Europe
- Asia Pacific
- Rest of the World
8. Global Pharmaceutical Marijuana (MMJ) Market Competitive Landscape
- Overview
- Company Market Ranking
- Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
